Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | OXTR | P30559 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10035322 | 0.87 | MKNK1 (0.47) | AVPR1ASMN1; SMN2HPGDOXTRALDH1A1 | |
| SCHEMBL10035347 | 0.87 | MKNK1 (0.47) | AVPR1ASMN1; SMN2HPGDOXTRALDH1A1 | |
| SCHEMBL10111049 | 0.86 | HPGD (0.45) | AVPR1ASMN1; SMN2HPGDOXTRKDM4E | |
| SCHEMBL10110929 | 0.84 | SMN1; SMN2 (0.46) | AVPR1ASMN1; SMN2HPGDOXTRKDM4E | |
| SCHEMBL10035334 | 0.84 | MKNK1 (0.49) | AVPR1A | |
| SCHEMBL8339889 | 0.82 | AVPR1A (0.78) | AVPR1ASMN1; SMN2HPGDOXTRKDM4E | |
| SCHEMBL4402535 | 0.82 | AVPR1A (0.78) | AVPR1ASMN1; SMN2HPGDOXTRKDM4E | |
| SCHEMBL13045336 | 0.81 | CNR2 (0.40) | AVPR1AALDH1A1L3MBTL1CNR1CNR2 | |
| SCHEMBL10126581 | 0.81 | SMN1; SMN2 (0.42) | AVPR1ASMN1; SMN2HPGDOXTRKDM4E | |
| SCHEMBL12230621 | 0.80 | AVPR1A (0.40) | AVPR1ASMN1; SMN2HPGDOXTRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404363-B2 | Organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8384286-B2 | Compound and organic light emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2013-02-26 | — | — | US | disclosed |
| US-8288017-B2 | Fused ring aromatic compound and organic light-emitting device using same | CANON KABUSHIKI KAISHA (JP) | 2012-10-16 | — | — | US | disclosed |
| US-8253325-B2 | Organic light-emitting device with microcavity structure and differing semi-transparent layer materials | CANON KABUSHIKI KAISHA (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20120056172-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-03-08 | — | — | US | disclosed |
| US-20120043535-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2012-02-23 | — | — | US | disclosed |
| US-20110204352-A1 | FUSED RING AROMATIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | CANON KABUSHIKI KAISHA (JP) | 2011-08-25 | — | — | US | disclosed |
| US-20110089822-A1 | ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2011-04-21 | — | — | US | disclosed |
| US-20110031515-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20080129192-A1 | ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110204352-A1 | FUSED RING AROMATIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | ARL1, TYR, OR10J3 | AVPR1A 2156/4885SMN1; SMN2 4577/4885HPGD 4425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.